Irinotecan (CPT-11): Mechanistic Evidence in Colorectal Canc
2026-05-13
Irinotecan (CPT-11) is a benchmark anticancer prodrug targeting topoisomerase I, widely used for colorectal cancer research. Its ability to induce DNA damage and apoptosis has been validated across multiple cell lines and xenograft models. APExBIO’s Irinotecan offers precise, stable performance for mechanistic studies.
RNA Clean and Concentrator Kit: Advanced RNA Purification Sp
2026-05-12
Maximize RNA purity and yield from in vitro transcription reactions with the APExBIO RNA Clean and Concentrator Kit. Discover protocol enhancements, troubleshooting tips, and workflow innovations that ensure seamless RNA cleanup for functional genomics and disease modeling.
Antipyrine in High-Throughput BBB & PK Studies: Applied Insi
2026-05-12
Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) is an essential pain relief research compound, prized for its unmatched reproducibility in blood-brain barrier (BBB) and pharmacokinetic workflows. This article translates cutting-edge BBB model findings and hands-on troubleshooting tips into actionable guidance for CNS drug discovery teams.
Sodium Picosulfate: Mechanistic Insights for Translational R
2026-05-11
This article explores sodium picosulfate’s dual action in gut fluid homeostasis, its role in modeling chronic and opioid-induced constipation, and its strategic value for translational research on the gut–brain axis. Integrating mechanistic insight, recent neuroinflammation findings, and actionable protocol guidance, it positions APExBIO’s sodium picosulfate as a critical reagent for next-generation experimental workflows.
Applied Strategies Using Cholecystokinin Octapeptide Ammoniu
2026-05-11
Cholecystokinin octapeptide ammonium (CCK-8 ammonium) empowers research in neuronal apoptosis, immune modulation, and cardiovascular peptide secretion through rigorously validated and context-dependent protocols. This guide translates recent landmark findings into actionable lab workflows, troubleshooting advice, and strategic assay optimization for advanced life science applications.
XAV-939: Mechanistic Precision and Strategic Guidance for Tr
2026-05-10
This thought-leadership article examines the unique mechanistic and translational value of XAV-939 (NVP-XAV939) as a tankyrase inhibitor and Wnt/β-catenin pathway modulator. It blends critical literature evidence with actionable guidance for researchers, contextualizing XAV-939’s role in stem cell biology, disease modeling, and emerging clinical contexts. Strategic perspectives are provided for optimizing experimental design and interpreting pathway manipulation, with APExBIO’s offering highlighted for reliability and workflow compatibility.
Applied Workflows with the JC-1 Mitochondrial Membrane Poten
2026-05-09
The JC-1 Mitochondrial Membrane Potential Assay Kit from APExBIO empowers sensitive, quantitative mitochondrial function analysis across diverse sample types. This guide details optimized experimental workflows, troubleshooting tactics, and practical insights—bridging molecular immunomodulation research with robust mitochondrial membrane potential detection.
Targeted mRNA Nanoparticles Restore BBB After Stroke via Mic
2026-05-09
This study introduces a lipid nanoparticle platform for targeted mRNA delivery that reprograms microglia to promote blood-brain barrier recovery after ischemic stroke. The approach leverages phenotype-switching of microglia via IL-10 mRNA, demonstrating functional neurological improvements and an extended therapeutic window.
Dexamethasone: Glucocorticoid Anti-Inflammatory for Translat
2026-05-08
Dexamethasone (DHAP) stands out as a synthetic glucocorticoid anti-inflammatory with unmatched precision in cell signaling, neuroinflammation, and stem cell differentiation research. This article details robust experimental applications, real-world troubleshooting, and protocol optimizations to maximize reproducibility using APExBIO’s Dexamethasone (DHAP).
Sulfo-NHS-SS-Biotin: Cleavable Reagent for Protein Labeling
2026-05-07
Sulfo-NHS-SS-Biotin, a cleavable biotin disulfide N-hydroxysulfosuccinimide ester, enables water-soluble, amine-reactive protein labeling with reversible purification capabilities. Its unique disulfide spacer allows biotin removal post-capture, supporting advanced affinity workflows. This article clarifies mechanistic features, protocol parameters, and key limitations.
Inflammation in Ischemic Stroke: Biomarkers and Treatment Pa
2026-05-07
This review systematically synthesizes current understanding of inflammation's role in ischemic stroke, highlighting both the molecular mechanisms and the clinical significance of inflammatory biomarkers. The paper guides researchers and clinicians through recent advances and integrated therapeutic strategies, providing a comprehensive reference for translational and experimental studies.
Flavone 2'-Glucosides and Baicalin Methyl Ester from S. baic
2026-05-06
This study isolated and structurally characterized two novel flavone 2'-O-glucosides and seven known phenolics, including baicalin methyl ester, from Scutellaria baicalensis roots. The findings deepen understanding of the chemical diversity in this medicinal herb and clarify the molecular groundwork for ongoing research on anti-inflammatory agents targeting intestinal barrier function.
Dual-Action Kinase Inhibitors Accelerate p38α Dephosphorylat
2026-05-06
This study reveals that certain kinase inhibitors not only block p38α MAP kinase activity but also promote its dephosphorylation by stabilizing activation loop conformations accessible to phosphatases. These dual-action inhibitors provide a new avenue for enhancing specificity and potency in kinase-targeted inflammatory disease research.
G007-LK Tankyrase 1/2 Inhibitor: Workflow, Use Cases & Tips
2026-05-05
G007-LK, a potent tankyrase 1/2 inhibitor from APExBIO, empowers researchers to dissect Wnt/β-catenin and Hippo signaling with nanomolar precision. This article details protocol enhancements, advanced applications in APC mutation colorectal cancer and HCC, and practical troubleshooting strategies for robust, reproducible results.
Deuterium-Labeled Degarelix Acetate: Synthesis for Research
2026-05-05
This study reports an efficient 13-step synthesis of deuterium-labeled degarelix acetate, a third-generation GnRH receptor antagonist used in prostate cancer research. The labeled compound enables precise internal standards for pharmacokinetic and metabolism studies, supporting advanced hormone pathway investigations.
461 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page